Previous 10 | Next 10 |
Endo International plc (ENDP) Q1 2021 Earnings Conference Call May 7, 2021 7:30 AM ET Company Participants Laure Park – Senior Vice President-Investor Relations and Corporate Affairs Blaise Coleman – President and Chief Executive Officer Mark Bradley – Executive Vice Pres...
Image source: The Motley Fool. Endo International plc (NASDAQ: ENDP) Q1 2021 Earnings Call May 7, 2021 , 7:30 a.m. ET Operator Continue reading For further details see: Endo International plc (ENDP) Q1 2021 Earnings Call Transcript
The following slide deck was published by Endo International plc in conjunction with their 2021 Q1 earnings call. For further details see: Endo International plc 2021 Q1 - Results - Earnings Call Presentation
Endo Reports First-Quarter 2021 Financial Results And Updates 2021 Financial Guidance PR Newswire DUBLIN , May 6, 2021 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today reported financial results for the first-quarter ended March 31, 2021. ...
Maverix Private Equity Announces Team Additions Canada NewsWire TORONTO , May 3, 2021 /CNW/ - Maverix Private Equity, a Toronto-based private equity firm which recently announced an inaugural USD $500 million growth-fund, has today announced th...
Endo's Qwo® (collagenase clostridium histolyticum-aaes) Data to Be Presented at The Aesthetic Meeting 2021 Canada NewsWire DUBLIN , April 29, 2021 /CNW/ -- Endo International plc (NASDAQ: ENDP) announced today that data relevant to the use of Endo Aesthetics...
Endo Implements Board Succession Plan Canada NewsWire Mark Barberio appointed Chairman of the Board of Directors effective at 2021 Annual General Meeting DUBLIN , April 27, 2021 /CNW/ -- Endo International plc (NASDAQ: ENDP) ("Endo" or the "Compa...
Four drugmakers are slated to go on trial today in California over claims they fueled the opioid crisis, including Johnson & Johnson (JNJ) and Teva Pharmaceutical (TEVA), Allergan (ABBV) and Endo International (ENDP).The proceedings that could help finalize multibillion-dollar settlements...
Endo International (ENDP) announces that Phase 3 data evaluating Qwo (collagenase clostridium histolyticum-aaes) for the treatment of moderate to severe cellulite in the buttocks of adult women was published in the journal Dermatologic Surgery.The results demonstrate that Qwo meaningfull...
Endo to Announce First Quarter 2021 Financial Results PR Newswire DUBLIN , April 13, 2021 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) will announce its first-quarter 2021 financial results on May 6, 2021 and members of its senior management tea...
News, Short Squeeze, Breakout and More Instantly...
Endo International plc Company Name:
ENDP Stock Symbol:
NASDAQ Market:
Endo International plc Website:
Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting Canada NewsWire DUBLIN , Sept. 21, 2023 /CNW/ -- Endo International plc (OTC:...
ENDO REPORTS SECOND-QUARTER 2023 FINANCIAL RESULTS Canada NewsWire DUBLIN , Aug. 8, 2023 /CNW/ -- Endo International plc (OTC: ENDPQ) today reported financial results for the second-quarter ended June 30, 2023 . SECOND-QUARTER FINANCIAL PERF...
Endo Launches PREVDUO™ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Pre-Filled Syringe Canada NewsWire The ready-to-use pre-filled syringe combines two well-known, FDA-approved product...